Molecular network study of pituitary adenomas
Pituitary adenomas are a category of neoplasms with a high degree of heterogeneity that occur in the central regulatory organ pituitary, which plays important roles in the hypothalamus–pituitary-targeted organ axis systems that impact on important physiological functions of human body. Rapidly devel...
Saved in:
HerausgeberIn: | |
---|---|
Sonstige: | |
Year of Publication: | 2020 |
Language: | English |
Physical Description: | 1 electronic resource (210 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545611604498 |
---|---|
ctrlnum |
(CKB)5400000000041401 (oapen)https://directory.doabooks.org/handle/20.500.12854/73744 (EXLCZ)995400000000041401 |
collection |
bib_alma |
record_format |
marc |
spelling |
Zhan, Xianquan edt Molecular network study of pituitary adenomas Frontiers Media SA 2020 1 electronic resource (210 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Pituitary adenomas are a category of neoplasms with a high degree of heterogeneity that occur in the central regulatory organ pituitary, which plays important roles in the hypothalamus–pituitary-targeted organ axis systems that impact on important physiological functions of human body. Rapidly developed multi-omics and systems biology are impacting on treatment of pituitary adenomas and changing the paradigms from the traditional single-factor strategy to a multi-parameter systematic strategy. A series of molecular alterations at different levels of genes (genome), RNAs (transcriptome), proteins (proteome), peptides (peptidome), metabolites (metabolome), and imaging characteristics (radiome) that resulted from exogenous and endogenous carcinogens are involved in pituitary tumorigenesis and mutually associate and function in a molecular network system, thus determines the difficulty in the use of a single molecule as biomarker to clarify its molecular mechanisms, and to predict, prevent, diagnose, and treat a pituitary adenoma. Of them, molecular network study plays central roles. A key molecule-panel biomarker that is derived from molecular network is necessary for accurately clinical practice of a pituitary adenoma. The modern multi-omics, computation biology, and systems biology technologies lead to the possibility in recognizing really reliable molecular-panel biomarker for research and clinical practice in pituitary adenomas. English Medicine bicssc Endocrinology bicssc pituitary adenoma signaling pathway molecular network multi-omics personalized medicine precision medicine therapeutic target molecule-panel biomarker 2-88963-602-X Desiderio, Dominic M. edt Zhan, Xianquan oth Desiderio, Dominic M. oth |
language |
English |
format |
eBook |
author2 |
Desiderio, Dominic M. Zhan, Xianquan Desiderio, Dominic M. |
author_facet |
Desiderio, Dominic M. Zhan, Xianquan Desiderio, Dominic M. |
author2_variant |
x z xz d m d dm dmd |
author2_role |
HerausgeberIn Sonstige Sonstige |
title |
Molecular network study of pituitary adenomas |
spellingShingle |
Molecular network study of pituitary adenomas |
title_full |
Molecular network study of pituitary adenomas |
title_fullStr |
Molecular network study of pituitary adenomas |
title_full_unstemmed |
Molecular network study of pituitary adenomas |
title_auth |
Molecular network study of pituitary adenomas |
title_new |
Molecular network study of pituitary adenomas |
title_sort |
molecular network study of pituitary adenomas |
publisher |
Frontiers Media SA |
publishDate |
2020 |
physical |
1 electronic resource (210 p.) |
isbn |
2-88963-602-X |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT zhanxianquan molecularnetworkstudyofpituitaryadenomas AT desideriodominicm molecularnetworkstudyofpituitaryadenomas |
status_str |
n |
ids_txt_mv |
(CKB)5400000000041401 (oapen)https://directory.doabooks.org/handle/20.500.12854/73744 (EXLCZ)995400000000041401 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Molecular network study of pituitary adenomas |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1787548717604143104 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02669nam-a2200409z--4500</leader><controlfield tag="001">993545611604498</controlfield><controlfield tag="005">20231214133041.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202111s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000041401</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/73744</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000041401</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zhan, Xianquan</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Molecular network study of pituitary adenomas</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (210 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pituitary adenomas are a category of neoplasms with a high degree of heterogeneity that occur in the central regulatory organ pituitary, which plays important roles in the hypothalamus–pituitary-targeted organ axis systems that impact on important physiological functions of human body. Rapidly developed multi-omics and systems biology are impacting on treatment of pituitary adenomas and changing the paradigms from the traditional single-factor strategy to a multi-parameter systematic strategy. A series of molecular alterations at different levels of genes (genome), RNAs (transcriptome), proteins (proteome), peptides (peptidome), metabolites (metabolome), and imaging characteristics (radiome) that resulted from exogenous and endogenous carcinogens are involved in pituitary tumorigenesis and mutually associate and function in a molecular network system, thus determines the difficulty in the use of a single molecule as biomarker to clarify its molecular mechanisms, and to predict, prevent, diagnose, and treat a pituitary adenoma. Of them, molecular network study plays central roles. A key molecule-panel biomarker that is derived from molecular network is necessary for accurately clinical practice of a pituitary adenoma. The modern multi-omics, computation biology, and systems biology technologies lead to the possibility in recognizing really reliable molecular-panel biomarker for research and clinical practice in pituitary adenomas.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Endocrinology</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pituitary adenoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">signaling pathway</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular network</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multi-omics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personalized medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">precision medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">therapeutic target</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecule-panel biomarker</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88963-602-X</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Desiderio, Dominic M.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhan, Xianquan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Desiderio, Dominic M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:40:46 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337956000004498&Force_direct=true</subfield><subfield code="Z">5337956000004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337956000004498</subfield></datafield></record></collection> |